Nature of Disclosure: Regulatory intimation of upcoming board meeting under SEBI Listing Regulations Regulation 29.
Key Dates:
- Board meeting scheduled for Monday, 2nd November, 2026
- Meeting venue: Company's Corporate Office at 4th Floor, Gopal Bhawan, 199, Princess Street, Mumbai – 400 002 (Maharashtra)
- Trading window reopening: Thursday, 5th November, 2026 (48 hours after results declaration)
Agenda Items:
The Board of Directors will consider and approve:
- Unaudited Standalone Financial Results for the quarter and half year ended 30th September, 2026
- Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2026
- Auditor's Limited Review Report on the financial results
Trading Restrictions:
In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prohibition of Insider Trading, the trading window closure remains in effect until 48 hours after the declaration of financial results. The trading window will reopen on Thursday, 5th November, 2026 for:
- Directors
- Key Managerial Personnel
- Designated Persons
- Connected Persons
Regulatory Compliance:
Shaleen Toshniwal, Managing Director (DIN: 00246432)